Qure.ai AI features and pricing (October 2026)

Qure.ai develops AI software for medical imaging that reads chest X-rays, head CT scans and lung CT scans. It serves hospitals, imaging centers, public health programs and pharmaceutical companies, with a focus on tuberculosis, lung cancer and stroke.

The product range includes qXR for chest X-ray reporting, qER for head CT in stroke and trauma, qCT for lung nodule quantification, qMSK for musculoskeletal X-rays and qTrack for care coordination in lung nodule programs. The Qure App shows images and AI results on mobile devices and alerts clinical teams, and Aira adds documentation and decision support for frontline health workers.

The software runs in the cloud on Amazon Web Services or Azure, or on premise. Qure.ai Technologies was founded in 2016 and is registered in Mumbai, with registered companies in New York and Birmingham. The vendor reports use in more than 105 countries through more than 5,500 sites.

• Pre-reads chest X-raysqXR analyzes chest X-rays and marks findings in the lungs, pleura, heart, mediastinum, bones and diaphragm; the vendor states processing takes under 20 seconds. It pre-fills reports and separates unremarkable images, so radiologists can clear backlogs and focus on abnormal studies.
• Triages head CT scansqER flags suspected intracranial hemorrhage, mass effect, midline shift and cranial fracture on non-contrast head CT. The product page notes that the US clearance covers bleeds only. Emergency teams see critical cases earlier and can involve specialists through alerts in the Qure App.
• Supports tuberculosis screeningFor TB programs, qXR reads chest X-rays where no human reader is available, a use the vendor says received WHO endorsement in 2021. Screening teams can refer suspected cases for confirmatory testing without waiting for a radiologist.
• Measures and risk-scores lung nodulesqCT locates lung nodules on CT, measures their volume with one click and tracks growth over time. It assigns malignancy risk based on guidelines such as Lung-RADS, Brock and Fleischner, which gives lung cancer programs a consistent basis for follow-up.
• Structures frontline recordsAira converts conversations, notes and registers into structured records and prompts next steps based on defined protocols. Program teams see gaps and risks across facilities, and health workers spend less time on manual data entry.

• Products hold FDA 510(k) clearances in the US and CE certification under EU MDR, with ISO 13485:2016 certified quality management under the MDSAP program.
• Runs in the cloud or on premise; the vendor states that data is de-identified before leaving a US hospital for cloud processing.
• Serves public health programs for tuberculosis screening and disease surveillance alongside hospital radiology and pharmaceutical research.

Qure.ai is registered in Mumbai and holds an approval from India's regulator CDSCO. Several products are FDA 510(k) cleared, and its UK page quotes clinicians from several NHS trusts as users.

In the US, check the cleared indications for each product, since FDA clearance differs by product and finding. In the UK, confirm the regulatory status of the exact product version and agree a data processing agreement under UK GDPR. Decide between cloud processing on Amazon Web Services or Azure and an on-premise installation, and ask for the cloud region. Pricing is only available on request.

No reviews yet. Be the first to share how your team uses it.

Every review shows its verification level. We read each one before it goes live. How we check reviews